Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$21.10
0.100.48%
Last update: Oct 15, 9:02 AM
$21.10
0.100.48%
Apollomics Inc (APLM) Stock Price, Quote, News & History
APLMNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Apollomics (NASDAQ:APLM) through any online brokerage.
Other companies in Apollomics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Apollomics has a consensus price target of $850.00.
The stock price for Apollomics (NASDAQ: APLM) is $21.1 last updated October 15, 2026 at 9:02 AM EDT.
There are no upcoming dividends for Apollomics.
Apollomics does not have any upcoming earnings scheduled.
There is no upcoming split for Apollomics.
Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
